Antares Pharma Inc. (ATRS) Starts Presentation at B. Riley Conference
Antares Pharma (NASDAQ: ATRS) is a combination drug device company focused on the development and commercialization of self-administered parenteral pharmaceutical products using advanced drug delivery auto injector technology. The company has a portfolio of proprietary and partnered commercial products with several product candidates in advanced stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries Ltd., AMAG Pharmaceuticals Inc. and Pfizer Inc. Antares Pharma’s proprietary products include XYOSTED (testosterone enanthate) injection, OTREXUP (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. For more information, visit the company's…







